Furthermore, BRAF V600K positive melanoma is considered to be more aggressive than V600E ones [42], underlying that the mutational load of BRAF-mutated melanoma should be considered as a key aspect in melanoma management [43]. This evidence concerns the gene BRAF and melanoma.